Forsyth scientists find three bacteria associated with oral cancer

000, in which the scientists compared bacterial samples from the saliva of 229 healthy subjects with samples from 45 patients who had been diagnosed with oral cancer. The team found elevated levels of three bacterial species (C. gingivalis, P. melaninogenica and S. mitis) in oral cancer patients. The scientists obtained similar findings when they controlled for gender, age, and smoking history.

According to Mager, "Those results led us to hypothesize that the three species could serve as diagnostic indicators for OSCC. And, in fact, we found that elevated salivary counts of the three bacteria correctly identified 80% of individuals with oral cancer and 83% of controls."

If their findings are replicated in future studies, the Forsyth team envisions a simple saliva test that could be administered by dental technicians in large screenings, mailed to a diagnostic center, and returned to doctors or dentists within several days.

The need for screening
Government statistics show that, every year, some 30 thousand US residents are diagnosed with oral cancer. Of those diagnosed, more than 90 per cent are found to have OSCC. If discovered and treated early, OSCC has a five-year survival rate of 80-to-90 percent. But 60 percent of OSCC cases are not diagnosed until the later stages and fewer than 54 per cent of individuals diagnosed in those stages live for five yearsXplacing OSCC among the deadliest of cancers.

"Far too many people are not diagnosed until their oral cancer is in its advanced stages," Mager said. In part, that is because, in its early stages, oral cancer may be asymptomatic or mimic benign conditions, so those who have it do not seek dental or medical care. "A saliva test would be an easy, non-invasive way to diagnose or monitor patients."

Until such a test exists, Mager added, "I cannot overemphasize how important it is for every adult to be examined by a dental or medical health professional for signs o


Page: 1 2 3

Related biology news :

1. Forsyth scientists gain new understanding of adult stem cell regulation
2. Forsyth scientists discover early key to regeneration
3. Forsyth scientists find linkages between serotonin reuptake inhibitors and bone mass
4. Forsyth scientists develop system for automated analysis of behavior
5. Forsyth issues imperative for a vaccine against cavities
6. Forsyth scientists gain greater understanding of how embryos differentiate left from right
7. New understanding of regeneration gained by Forsyth scientists
8. Forsyth scientists identify a gene responsible for facial diversity
9. Brain chemical serotonin involved in early embryo patterning, Forsyth scientists find
10. Forsyth scientists find blue light fights gum disease culprits
11. UK scientists working to help cut ID theft

Post Your Comments:

(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
Cached News: